Cytek Biosciences (CTKB) EBITDA (2020 - 2026)
Cytek Biosciences (CTKB) posted EBITDA of -$18.5 million for Q1 2026, down 230.05% on a QoQ basis from -$5.6 million in Q4 2025, and down 23.29% year-over-year from -$24.1 million in Q1 2025.
Cytek Biosciences (CTKB) EBITDA (2020 - 2026) Analysis & Trends
Cytek Biosciences' EBITDA history runs 7 years deep, the most recent figure standing at -$18.5 million for Q1 2026.
- Quarterly EBITDA fell 23.29% year-over-year to -$18.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$43.9 million (down 77.16% YoY) and the FY2025 annual result came in at -$40.4 million, down 96.77% from the prior year.
- EBITDA was -$18.5 million for Q1 2026 at Cytek Biosciences, down from -$5.6 million in the prior quarter.
- Across five years, EBITDA topped out at $3.0 million in Q4 2024 and bottomed at -$18.5 million in Q1 2026.
- A 5-year average of -$6.4 million and a median of -$6.4 million in 2023 frame the typical range for EBITDA.
- Annual changes were most pronounced in 2023 — EBITDA plunged 924.35% — and 2024, when it surged 2279.56%.
- Cytek Biosciences' EBITDA stood at $84000.0 in 2022, then sank by 263.1% to -$137000.0 in 2023, then jumped by 2279.56% to $3.0 million in 2024, then plunged by 287.34% to -$5.6 million in 2025, then sank by 230.05% to -$18.5 million in 2026.
- Business Quant data shows CTKB's EBITDA at -$18.5 million in Q1 2026, -$5.6 million in Q4 2025, and -$9.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 255.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Cytek Biosciences | 586.89 Mn | 521.19 Mn | 21.25 Mn | -18.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.46 Mn |
| Dec 31, 2025 | -5.59 Mn |
| Sep 30, 2025 | -9.19 Mn |
| Jun 30, 2025 | -10.62 Mn |
| Mar 31, 2025 | -14.98 Mn |
| Dec 31, 2024 | 2.99 Mn |
| Sep 30, 2024 | -4.25 Mn |
| Jun 30, 2024 | -8.53 Mn |
| Mar 31, 2024 | -10.73 Mn |
| Dec 31, 2023 | -137,000.00 |
| Sep 30, 2023 | -6.42 Mn |
| Jun 30, 2023 | -9.13 Mn |
| Mar 31, 2023 | -12.16 Mn |
| Dec 31, 2022 | 84,000.00 |
| Sep 30, 2022 | 1.36 Mn |
| Jun 30, 2022 | -891,000.00 |
| Mar 31, 2022 | -2.36 Mn |
| Dec 31, 2021 | 1.32 Mn |
| Sep 30, 2021 | 2.90 Mn |
| Jun 30, 2021 | 3.81 Mn |